Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

'Coin Stories' host Natalie Brunell shares Bitcoin basics and tips

Check out the above video for Bitcoin Basics with “Coin Stories” podcast host and Bitcoin expert Natalie Brunell . In this must-watch interview, Brunell breaks down the basics of Bitcoin saying, “anyone can learn” and tha...
Coreena Robertson | 15 hours ago |

Buzz on the Bullboards: A recap of recent activity and stocks in focus

Last week witnessed a flurry of stock activity on Bay Street in Toronto and Wall Street in New York, as investors grappled with market volatility and shifting dynamics. After a major sell-off, markets have been on edge, closely monitoring corporate earnings and other key ...
Jonathon Brown | 7 days ago |

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon | April 11, 2024 |

Desert Gold, Barrick, Intel: Will U.S. stagflation push gold higher?

Gold has reached another record level of over US$2,300 per ounce. Investors are betting that the U.S. Federal Reserve will cut interest rates later this year. Gold has been on an upward trend since mid-February. On the one hand, it has a reputation for maintaining or...
Juliane Zielonka | April 8, 2024 |

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...
Jonathon Brown | March 28, 2024 |

Buzz on the Bullboards: Upbeat U.S. earnings good news for all?

Do rising tides truly lift all ships? We are in the midst of a strong earnings season and U.S. markets have reacted in kind. Strong earnings growth pushed Wall Street indices towards fresh record highs this past week. While activity moved lower earlier on, the belief ...
Jonathon Brown | February 8, 2024 |

Strategic growth, EBITDA success and new leadership: Ciscom's Q3 2023 update

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Today we are talking with Ciscom Corp. (CSE:CISC) , which is focused on technology-driven marketing and advertising and content management organizations. ...
Brieanna McCutcheon | January 29, 2024 |

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...
Jonathon Brown | January 25, 2024 |

Buzz on the Bullboards: Tracking Bombardier’s path, Tilray’s growth

This year began on a confusing path for investors as sectors struggle under greater inflation costs and hopes of an imminent interest rate cut fade. A few weeks later in 2024, we are starting to see a clearer picture of where many companies are headed this year. M...
Jonathon Brown | January 18, 2024 |

Zacks Small-Cap Research initiates coverage of Medicus Pharma (TSXV:MDCX)

Click here to download the report. This is third-party provided content issued on behalf of Medicus Pharma Ltd. (TSXV:MDCX) , please see full disclaimer here . Join the discussion: Find out what everybody’s saying about this stock on ...
Research | January 10, 2024 |
1 2 3 4 5 6 7 8 9 10 ...